Company intelligence / Profile preview

Beijing Cheng Da Tianhe Biotechnology

Beijing, Beijing, China

Ownership: Private
Development stage: Other

Overview

Beijing Cheng Da Tianhe Biotechnology is a specialized biotechnology company focused on the research, development, and production of human vaccines. As a subsidiary of Liaoning Cheng Da Biotechnology (Chengda Bio), the company leverages advanced Vero cell culture technology to manufacture high-quality biological products. Its primary portfolio includes vaccines for rabies and hemorrhagic fever with renal syndrome (HFRS). The company operates out of the Zhongguancun Science Park in Beijing, contributing significantly to China's domestic vaccine supply and public health infrastructure.

Therapeutic areas: Infectious Diseases
Modalities: VaccineBiologic
Industry: Biotech

Beyond the preview

Go deeper on Beijing Cheng Da Tianhe Biotechnology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beijing Cheng Da Tianhe Biotechnology.

Explore the full profile